Steris

A $1 Billion Global Opportunity for Mobile Operating Tables by 2026 - New Research from StrategyR

Retrieved on: 
Thursday, October 21, 2021

SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Mobile Operating Tables - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Mobile Operating Tables - Global Market Trajectory & Analytics" .
  • (TKB Group); Schaerer Medical USA, Inc.; Siemens AG; Skytron LLC; Steris PLC; Stryker Corporation; UFSK-International OSYS GmbH and Others.
  • This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, September 30, 2021

In this report the global healthcare analytical testing services market is segmented by type, end user, and region.

Key Points: 
  • In this report the global healthcare analytical testing services market is segmented by type, end user, and region.
  • Based on type, the market is segmented into bioanalytical testing, physical characterization, method development & validation, stability testing, batch-release testing, raw material testing, microbial testing, and environmental monitoring services.
  • The bioanalytical testing segment holds the highest market share, by type, in the healthcare analytical testing services market, in the forecast period.
  • North America holds the highest market share, by region, in the forecast period
    The healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, September 30, 2021

In this report the global healthcare analytical testing services market is segmented by type, end user, and region.

Key Points: 
  • In this report the global healthcare analytical testing services market is segmented by type, end user, and region.
  • Based on type, the market is segmented into bioanalytical testing, physical characterization, method development & validation, stability testing, batch-release testing, raw material testing, microbial testing, and environmental monitoring services.
  • The bioanalytical testing segment holds the highest market share, by type, in the healthcare analytical testing services market, in the forecast period.
  • North America holds the highest market share, by region, in the forecast period
    The healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Global Sterilization Equipment and Disinfectants Market Opportunities and Strategies to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 16, 2021

Going forward, demand for sterilization equipment and disinfectants due to COVID-19, demand for critical care equipment due to COVID-19, relaxation in government regulations, and increasing prevalence of chronic diseases will drive the market for sterilization equipment and disinfectants.

Key Points: 
  • Going forward, demand for sterilization equipment and disinfectants due to COVID-19, demand for critical care equipment due to COVID-19, relaxation in government regulations, and increasing prevalence of chronic diseases will drive the market for sterilization equipment and disinfectants.
  • The sterilization equipment and disinfectants market is segmented by product type into sterilization equipment; and disinfectants.
  • The disinfectants market was the largest segment of the sterilization equipment and disinfectants market segmented by product type, accounting for 54.4% of the total in 2019.
  • Going forward sterilization equipment segment is expected to be the fastest growing segment in the sterilization equipment and disinfectants market, at a CAGR of 8.9%.

Alegeus Appoints Industry Veteran Jacqueline Kosecoff to Its Board of Directors

Retrieved on: 
Wednesday, September 8, 2021

Alegeus , the market leader in consumer funding technology, today announced it has named Jacqueline Kosecoff to its Board of Directors, effective immediately.

Key Points: 
  • Alegeus , the market leader in consumer funding technology, today announced it has named Jacqueline Kosecoff to its Board of Directors, effective immediately.
  • Dr. Kosecoff is a seasoned corporate executive and board member with special depth of knowledge in health services and technology.
  • She also sits on the board of directors of public companies, including Alignment Healthcare, GoodRx, Houlihan Lokey, STERIS plc and TriNet Group.
  • Were thrilled to welcome Jackie as a member of our Board of Directors, said Leif OLeary, Alegeus CEO.

Global Sterilization Equipment Markets, 2021-2026 - Increasing Outsourcing of Sterilization Creates Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 7, 2021

The Global Sterilization Equipment Market is estimated to be USD 11.35 Bn in 2021 and is expected to reach USD 16.6 Bn by 2026, growing at a CAGR of 7.9%.

Key Points: 
  • The Global Sterilization Equipment Market is estimated to be USD 11.35 Bn in 2021 and is expected to reach USD 16.6 Bn by 2026, growing at a CAGR of 7.9%.
  • The sterilization process is mandatory in producing pharmaceutical and biotechnological products, thereby increasing the application of sterilization equipment.
  • The Global Sterilization Equipment Market is segmented further based on Products and Services, End User, and Geography.
  • By Products and Services, the market is classified into sterilization instruments, sterilization services, and sterilization consumables & accessories.

Environmental Disinfection Robot Market to grow at almost 41% CAGR during 2021-2025 | Technavio

Retrieved on: 
Monday, August 16, 2021

Buy our market report now to gain access to detailed analysis on the environmental disinfection robot market: https://www.technavio.com/talk-to-us?report=IRTNTR43329

Key Points: 
  • Buy our market report now to gain access to detailed analysis on the environmental disinfection robot market: https://www.technavio.com/talk-to-us?report=IRTNTR43329
    Environmental Disinfection Robot Market 2021-2025: Vendor Analysis and Scope
    Some of the major vendors of the environmental disinfection robot market in the industrial machinery industry include Blue Ocean Robotics, Ecolab Inc., Finsen Technologies Ltd., Mediland Enterprise Corp., Professional Disposables International Inc., Steriliz LLC, STERIS Plc, Surfacide, The Clorox Co., and Xenex Disinfection Services LLC.
  • To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market.
  • The report also covers the following areas:
    The environmental disinfection robot market is fragmented, and the degree of fragmentationwill accelerate.
  • Backed with competitive intelligence and benchmarking, our research reporton the environmental disinfection robot market is designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.

STERIS Announces Financial Results for Fiscal 2022 First Quarter

Retrieved on: 
Monday, August 9, 2021

First quarter revenue increases 45% as reported; 21% constant currency organic

Key Points: 
  • First quarter revenue increases 45% as reported; 21% constant currency organic
    DUBLIN, IRELAND, Aug. 09, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (STERIS or the Company) today announced financial results for its fiscal 2022 first quarter ended June 30, 2021.
  • Constant currency organic revenue (see Non-GAAP Financial Measures) increased 21% for the first quarter of fiscal 2022 as compared to the first quarter of fiscal 2021, which was negatively impacted by the pandemic.
  • Fiscal 2022 first quarter was negatively impacted by approximately $140 million in one-time expenses associated with the Cantel Medical acquisition.
  • Operating income was $49.1 million in the first quarter of fiscal 2022 compared with $48.5 million in the prior years first quarter.

STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021

Retrieved on: 
Tuesday, July 27, 2021

Other risk factors are described in STERISs other securities filings, including Item 1A of our Annual Report on Form 10-K for the year ended March 31, 2021.

Key Points: 
  • Other risk factors are described in STERISs other securities filings, including Item 1A of our Annual Report on Form 10-K for the year ended March 31, 2021.
  • Many of these important factors are outside of STERISs control.
  • References to products are summaries only and should not be considered the specific terms of the product clearance or literature.
  • Unless legally required, STERIS does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized.

FDA Approves Expanded Sterilization and Disinfectant Methods for the LUMINELLE® DTx System

Retrieved on: 
Monday, July 12, 2021

This expansion will allow the LUMINELLE DTx System to be more fully utilized in broader settings such as Hospital Systems and Outpatient Surgical Centers.

Key Points: 
  • This expansion will allow the LUMINELLE DTx System to be more fully utilized in broader settings such as Hospital Systems and Outpatient Surgical Centers.
  • The newly approved reprocessing methods include the Steris Revital-Ox RESERT HLD as a high-level disinfectant method and the Steris V-PRO Low Temperature Sterilization as a sterilization method for the LUMINELE DTx System.
  • Currently, Metricide OPA Plus high-level disinfectant and Anderson Scientific's Flexible Bag Ethylene Oxide sterilization are approved for the LUMINELLE DTx System.
  • The LUMINELLE DTx System is FDA cleared for both diagnostic and therapeutic hysteroscopy and cystoscopy.